Broadly Neutralizing Antibody Treatment Maintained HIV Suppression in Children with Favorable Reservoir Characteristics in Botswana

Researchers conducted a prospective clinical trial with two HIV-1 broadly neutralizing antibodies in children who had previously initiated small-molecule antiretroviral treatment treatment before seven days of age and who continued treatment for at least 96 weeks.